<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">341</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 111.160 L98.110 111.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 704.160 L109.610 704.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P621</text>
   <text y="87.957" x="62.362,69.364,71.866,75.367,78.364,82.864,90.361,92.863,97.867,101.863,104.113,111.115,115.615,117.865,121.861,125.857,129.853,133.849,138.853,141.85,146.35,150.346,152.596,157.6,161.596,166.096,170.596,173.593,176.095,180.595,184.591,187.093,191.593,193.843,197.839,201.835,206.335,211.339,213.841,218.341,221.338,225.334,228.835" svgx:width="0.78,0.28,0.39,0.33,0.5,0.83,0.28,0.56,0.44,0.25,0.78,0.5,0.25,0.44,0.44,0.44,0.44,0.56,0.33,0.5,0.44,0.25,0.56,0.44,0.5,0.5,0.33,0.28,0.5,0.44,0.28,0.5,0.25,0.44,0.44,0.5,0.56,0.28,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Histamine H3 receptor negatively regulates </text>
   <text y="98.955" x="62.362,66.862,69.364,71.866,76.366,80.866,85.87,89.866,94.87,99.874,103.87,108.37,112.366,116.866,119.863,123.859,126.109,131.113,133.615,136.612,139.609,143.605,147.601,151.597,156.601,159.598,162.1,166.6,169.597,172.099,176.599,181.603,183.853,188.353,193.357,198.361,200.611,208.108,212.608,216.604,219.106,221.608,226.612,231.112,234.109,236.611,241.111" svgx:width="0.5,0.28,0.28,0.5,0.5,0.56,0.44,0.56,0.56,0.44,0.5,0.44,0.5,0.33,0.44,0.25,0.56,0.28,0.33,0.33,0.44,0.44,0.44,0.56,0.33,0.28,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.56,0.56,0.25,0.83,0.5,0.44,0.28,0.28,0.56,0.5,0.33,0.28,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">oligodendrocyte differentiation and myelination</text>
   <text y="109.953" x="62.362,68.365,74.368,76.618,85.114,89.11,93.61" svgx:width="0.67,0.67,0.25,0.94,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RR Wang</text>
   <text y="107.439" x="98.11" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="101.035,103.285,105.535,112.033,114.283,120.286,124.786,128.782" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, Y Chen</text>
   <text y="107.439" x="133.281" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="136.206,138.456,140.706,146.205,148.455,154.953,159.453" svgx:width="0.25,0.25,0.61,0.25,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Guo</text>
   <text y="107.439" x="163.953" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="166.878,169.128,171.378,179.874,182.124,187.623,192.123,196.119" svgx:width="0.25,0.25,0.94,0.25,0.61,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Zhen</text>
   <text y="107.439" x="200.619" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="203.544,205.794,208.044,213.543,219.546,221.796,228.294,232.794" svgx:width="0.25,0.25,0.61,0.67,0.25,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, TB Guo</text>
   <text y="107.439" x="237.294" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="240.219,242.469,244.719,250.722,257.22,259.47,264.969,269.469,273.465" svgx:width="0.25,0.25,0.67,0.72,0.25,0.61,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, RY Zhao</text>
   <text y="107.439" x="277.964" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="109.959" x="280.889,283.139" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="120.957" x="62.36,68.858,75.356,77.606,83.105,85.607" svgx:width="0.72,0.72,0.25,0.61,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AA Liu</text>
   <text y="118.439" x="90.109" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="93.034,95.284,97.534,101.035,106.039,108.289,114.292,118.792,123.292,125.794" svgx:width="0.25,0.25,0.39,0.56,0.25,0.67,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JP Rubio</text>
   <text y="118.439" x="130.294" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="120.959" x="133.219,135.469,137.719,144.217,146.467,152.965,155.962,160.462,162.964" svgx:width="0.25,0.25,0.72,0.25,0.72,0.33,0.5,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Krull</text>
   <text y="118.439" x="165.465" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="120.959" x="168.39,170.64,172.89,176.391,178.641,184.14" svgx:width="0.25,0.25,0.39,0.25,0.61,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Lu</text>
   <text y="118.439" x="188.64" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="191.565,193.815,196.065,204.066,206.316,211.32,215.82,220.32" svgx:width="0.25,0.25,0.89,0.25,0.56,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Song</text>
   <text y="118.439" x="224.82" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="227.745,229.995,232.245,237.249,239.499,244.998,249.498,253.998,261.0,265.5,269.001,273.501" svgx:width="0.25,0.25,0.56,0.25,0.61,0.5,0.5,0.78,0.5,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, P Thompson</text>
   <text y="118.439" x="278.001" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="280.926,283.176" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="131.957" x="62.361,67.365,69.615,78.111,82.107,86.607" svgx:width="0.56,0.25,0.94,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">S Wang</text>
   <text y="129.439" x="91.108" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="131.959" x="94.033,96.283,98.533,102.034,108.037,110.287,116.29,118.792,122.788,127.288,131.284,134.281,138.781,142.282,146.782" svgx:width="0.25,0.25,0.39,0.67,0.25,0.67,0.28,0.44,0.5,0.44,0.33,0.5,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JC Richardson</text>
   <text y="129.439" x="151.281" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="140.437" x="62.361" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="142.959" x="65.258,71.711,74.168,78.623,82.574,87.029,91.484,97.937,100.394,102.851,107.306,113.264,115.721,118.178,122.633,126.584,128.789,130.994,136.448,143.405,149.858,152.063,154.52,158.975,161.18,165.635,170.09,174.545,179.0,183.455,187.91,192.365,194.822,197.027,199.232,203.687,208.142,212.597,217.052,221.507,225.962,230.417,232.874,235.079,237.284,243.242,247.697,250.154,254.609,259.064,261.314" svgx:width="0.72,0.28,0.5,0.44,0.5,0.5,0.72,0.28,0.28,0.5,0.67,0.28,0.28,0.5,0.44,0.25,0.25,0.61,0.78,0.72,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.25,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.25,0.67,0.5,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">GlaxoSmithKline, R&amp;D in Shanghai, Shanghai, China, </text>
   <text y="151.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="153.959" x="65.258,71.711,74.168,78.623,82.574,87.029,91.484,97.937,100.394,102.851,107.306,113.264,115.721,118.178,122.633,126.584,128.789,130.994,136.448,143.405,149.858,152.063,158.021,161.972,166.427,168.884,172.835,176.291,178.496,180.701,185.156,187.613,191.564,195.515,199.466,203.921,208.376,212.831,216.782,218.987,221.192,227.645,232.1,234.557,237.014,240.965,245.42,247.625,253.583,256.04,260.495,264.95,269.405,273.86,280.313,282.563" svgx:width="0.72,0.28,0.5,0.44,0.5,0.5,0.72,0.28,0.28,0.5,0.67,0.28,0.28,0.5,0.44,0.25,0.25,0.61,0.78,0.72,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">GlaxoSmithKline, R&amp;D Center, Stevenage, United Kingdom, </text>
   <text y="162.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="164.959" x="65.258,71.711,74.168,78.623,82.574,87.029,91.484,97.937,100.394,102.851,107.306,113.264,115.721,118.178,122.633,126.584,128.789,130.994,136.448,143.405,149.858,152.063,158.021,161.972,166.427,168.884,172.835,176.291,178.496,180.701,186.155,190.106,193.562,197.513,201.968,205.424,209.375,213.83,216.035,220.994,224.45,226.907,231.362,235.817,240.272,242.729,246.68,248.885,254.339,258.794,262.25,266.201,268.406,270.611,276.569,282.527,284.777" svgx:width="0.72,0.28,0.5,0.44,0.5,0.5,0.72,0.28,0.28,0.5,0.67,0.28,0.28,0.5,0.44,0.25,0.25,0.61,0.78,0.72,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.56,0.39,0.28,0.5,0.5,0.5,0.28,0.44,0.25,0.61,0.5,0.39,0.44,0.25,0.25,0.67,0.67,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">GlaxoSmithKline, R&amp;D Center, Research Triangle Park, NC, </text>
   <text y="175.957" x="62.36,68.813,73.268,75.725,78.182,82.133,86.588,88.793,93.248,95.705,100.16,102.617,106.568" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States</text>
   <text y="202.957" x="62.36,68.363,72.863,76.859,81.863,86.363,90.197,94.697,99.701,104.705,109.709,112.706" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="202.957" x="115.181,121.184,123.659,128.159,132.659,137.159,141.155,143.63,148.13,152.63,159.632,163.628,166.13,168.605,175.607,179.603,184.103,186.605,190.601,194.597,197.099,199.574,204.074,208.07,212.066,216.566,219.041,223.037,227.537,230.039,233.54,236.042,239.543,242.018,244.52,249.02,251.495,255.995,259.991,264.491,268.487,270.989,275.489,279.989,286.991,290.987,295.487,297.989" svgx:width="0.72,0.25,0.5,0.5,0.5,0.44,0.25,0.5,0.5,0.78,0.44,0.28,0.25,0.78,0.44,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.44,0.5,0.28,0.39,0.28,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A huge unmet medical need exists in development </text>
   <text y="213.955" x="62.36,66.86,69.857,71.927,76.427,80.423,86.921,88.991,91.493,94.49,98.486,102.482,104.984,111.986,115.982,120.482,122.984,125.054,129.554,133.55,136.547,140.543,145.043,147.545,152.045,159.047,162.548,164.618,167.12,171.62,173.69,176.687,180.683,185.183,189.179,191.681,194.678,196.748,203.75,208.25,212.246,214.748,217.25,221.75,223.82,226.322,230.822,232.892,237.392,241.388,243.89,246.392,250.388,254.888,257.39,260.891,262.961,269.459,271.961,274.463,278.963,281.033,288.035,292.535,295.037" svgx:width="0.5,0.33,0.25,0.5,0.44,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.44,0.5,0.28,0.5,0.78,0.39,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.44,0.28,0.33,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of new treatment paradigms to repair myelin in patients with mul-</text>
   <text y="224.953" x="62.36,64.862,67.364,71.864,74.366,78.362,81.134,84.635,88.631,91.133,95.129,98.126,102.626,106.127,108.629,112.13,114.902,117.899,125.9,130.904,133.901,136.151,138.428,144.926,149.426,153.422,157.922,160.424,163.925,166.697,173.195,177.695,180.197,184.193,188.693,191.465,195.461,199.457,203.957,206.729,211.229,214.226,218.726,225.728,230.228,232.73,236.726,239.498,243.998,246.5,249.002,253.502,258.002,262.502,266.498,270.998,275.498,278.495,282.995,286.991,291.491,293.993,297.989" svgx:width="0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.72,0.5,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.44,0.44,0.5,0.25,0.5,0.33,0.5,0.78,0.5,0.28,0.44,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tiple sclerosis (MS). Agents which can promote oligodendrocyte </text>
   <text y="235.951" x="62.36,66.86,69.857,73.853,77.849,82.349,85.346,88.847,93.347,96.344,98.702,102.698,106.694,109.196,111.698,114.056,117.053,123.551,128.555,134.558,137.555,139.913,144.413,146.915,149.75,152.747,156.743,159.74,163.736,168.236,170.738,173.24,177.236,179.738,182.24,186.74,191.24,193.598,197.594,200.591,204.587,206.945,210.941,215.441,219.941,223.442,225.944,230.444,234.44,237.437,241.433,245.933,248.291,250.793,255.293,257.651,262.151,266.651,270.152,273.653,277.649,281.15,284.651,287.009,289.511,294.011,298.007" svgx:width="0.5,0.33,0.44,0.44,0.5,0.33,0.39,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.25,0.33,0.72,0.56,0.67,0.33,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">precursor cell (OPC) differentiation are considered to possess the </text>
   <text y="246.949" x="62.36,66.86,71.36,73.862,77.858,82.358,84.86,87.362,91.358,93.86,95.57,98.072,102.572,104.273,108.269,112.265,116.261,120.257,122.759,126.755,129.752,133.748,136.25,140.246,142.748,145.745,149.741,153.242,155.744,160.244,163.241,167.237,168.938,173.438,177.434,179.936,182.438,186.434,190.934,192.644,195.641,199.637,206.639,211.139,215.135,217.637,220.139,224.639,228.635,231.137,233.639,238.139,242.639,244.34,246.842,251.342,253.052,261.053,266.057,267.758,272.258,276.254,278.756,281.258,285.254,289.754,292.256,295.757,298.007" svgx:width="0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.28,0.5,0.25,0.44,0.44,0.44,0.44,0.28,0.44,0.33,0.44,0.28,0.44,0.28,0.33,0.44,0.39,0.28,0.5,0.33,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">potential to accelerate/restore halted remyelination in MS patients, </text>
   <text y="257.947" x="62.36,66.86,71.36,73.862,76.112,79.613,84.113,86.363,89.36,93.356,96.353,98.603,103.103,107.099,110.096,114.596,116.846,119.843,123.839,130.337,132.587,135.089,139.589,143.585,146.582,150.578,155.078,159.074,163.574,166.076,168.578,172.574,174.824,177.326,181.322,184.157,188.657,192.653,195.155,198.656,200.906,205.406,209.402,213.902,217.898,220.148,224.648,228.644,232.64,237.14,239.39,241.892,246.392,250.388,254.888,257.39,259.892,262.889,265.391,269.387,273.887" svgx:width="0.5,0.5,0.28,0.25,0.39,0.5,0.25,0.33,0.44,0.33,0.25,0.5,0.44,0.33,0.5,0.25,0.33,0.44,0.72,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">but so far very few therapeutic targets have been identified.</text>
   <text y="268.945" x="62.36,69.362,74.366,77.363,81.359,85.355,88.352,90.854,95.354,99.35,102.851,105.848" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="268.945" x="107.999,112.868,117.368,119.519,122.021,126.521,130.517,135.017,137.519,140.021,143.018,147.518,149.669,154.169,158.669,163.169,167.165,169.667,171.818,174.32,178.316,181.151,185.651,189.647,192.149,195.65,197.801,200.303,204.803,206.954,209.456,213.956,218.456,222.956,226.952,230.948,233.099,236.096,240.092,247.094,251.594,255.59,258.092,260.594,265.094,269.09,271.592,274.094,278.594,283.094,285.344,287.495,293.993,297.989" svgx:width="0.61,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.5,0.5,0.44,0.28,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.72,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To identify novel targets to induce remyelination, we </text>
   <text y="279.943" x="62.36,66.356,69.857,72.359,76.355,80.855,83.357,85.859,89.36,93.86,97.856,102.356,104.318,108.314,112.814" svgx:width="0.44,0.39,0.28,0.44,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">established an </text>
   <text y="279.943" x="114.776,117.278,121.778,123.74,127.736,130.238,132.74,135.908" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="279.943" x="140.408,142.37,146.87,149.372,152.207,155.204,159.2,162.197,166.193,170.693,173.195,175.697,179.693,182.195,184.697,189.197,193.697,195.659,199.655,203.156,206.657,210.653,215.153,217.115,223.613,226.115,228.617,233.117,235.079,238.076,242.072,244.574,246.536,251.036,254.033,256.535,263.537,267.533,270.53,275.03,276.992,283.49,288.494,294.497,297.998" svgx:width="0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.39,0.39,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.25,0.5,0.33,0.28,0.78,0.44,0.33,0.5,0.25,0.72,0.56,0.67,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> differentiation assay with rat primary OPCs </text>
   <text y="290.941" x="62.36,64.862,69.362,71.612,75.113,79.109,82.106,86.102,90.098,94.598,96.848,103.346,108.35,114.848,117.845,122.345,125.342,129.842,134.342,137.339,139.841,143.837,146.339,150.335,153.332,157.832,160.082,164.078,168.578,173.078,177.578,180.08,184.076,186.578,190.574,195.074,197.324,199.826,202.328,206.828,209.825,213.821,216.818,219.32,223.316,226.817" svgx:width="0.28,0.5,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.25,0.72,0.56,0.72,0.33,0.5,0.33,0.5,0.5,0.33,0.28,0.44,0.28,0.44,0.33,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.28,0.5,0.33,0.44,0.33,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to screen GSK-proprietary annotated libraries.</text>
   <text y="301.939" x="62.36,70.856,74.852,77.849,82.853,87.353,92.357,95.858,98.855" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="301.939" x="100.898,106.397,110.897,114.893,116.936,120.932,125.432,132.434,136.934,141.434,145.934,150.434,154.934,158.435,160.478,164.474,168.974,173.474,175.517,178.514,182.51,185.012,189.008,191.51,195.506,200.006,202.049,204.551,208.547,211.382,215.882,219.878,222.38,225.881,227.924,234.422,238.418,241.415,245.411,247.454,249.956,254.456,258.452,262.952,264.995,269.495,273.491,275.993,278.495,282.995,286.991,289.493,293.489,297.989" svgx:width="0.61,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The compounds and related targets were then validated </text>
   <text y="312.937" x="62.36,64.862,69.362,72.359,76.859,81.359,85.859,90.359,92.762,96.758,99.161,102.662,106.658,109.655,112.157,116.153,119.654,122.048,126.548,129.545" svgx:width="0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.44,0.25,0.39,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">through a series of </text>
   <text y="312.937" x="131.948,134.45,138.95,141.353,145.349,147.851,150.353,153.521" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="312.937" x="158.021,160.415,164.411,168.911,173.411" svgx:width="0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> and </text>
   <text y="312.937" x="175.814,178.316,182.816,185.219,189.215,191.717,195.713" svgx:width="0.28,0.5,0.25,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vivo</text>
   <text y="312.937" x="200.213,202.616,206.612,210.113,213.614,217.61,222.11,225.611,227.861,230.255,232.757,235.007,239.003,241.253,243.656,247.652,251.648,254.645,258.641,263.141,267.137,269.639,272.141,276.137,279.134,281.528,285.029,287.531,290.033,294.029,298.025" svgx:width="0.25,0.44,0.39,0.39,0.44,0.5,0.39,0.25,0.25,0.28,0.25,0.44,0.25,0.25,0.44,0.44,0.33,0.44,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.39,0.28,0.28,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> assays, i.e. cerebellar slice </text>
   <text y="323.935" x="62.36,66.356,69.857,73.358,77.354,81.269,83.519,86.399,90.899,94.895,99.395,103.391,106.388,110.888,114.884,118.385,122.381,126.881,129.761,136.763,140.759,145.259,147.761,152.261,156.761,159.263,163.259,165.761,168.263,172.763,177.263,179.513,182.393,186.389,190.889,195.389,198.386,200.888,204.884,209.384,213.884,217.88,220.76,227.762,232.262,236.762,240.758,243.26,246.14,250.136,254.636,259.136,262.016,266.516,270.512,273.014,277.514,282.014,284.516,289.016,293.516,298.016" svgx:width="0.44,0.39,0.39,0.44,0.5,0.25,0.25,0.5,0.44,0.5,0.44,0.33,0.5,0.44,0.39,0.44,0.5,0.25,0.78,0.44,0.5,0.28,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.44,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">assay, gene-based manipulation, cuprizone model and pathology </text>
   <text y="334.933" x="62.36,66.356,70.856,74.852,77.354,81.854,85.355,87.857,91.358,93.608,100.106,102.608,105.11,109.61,111.86,119.861,124.865,127.115,130.616,134.612,141.614,146.114,148.616,152.612,156.113" svgx:width="0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">analysis with MS samples.</text>
   <text y="345.931" x="62.36,68.723,72.584,75.95,80.819,83.186,86.048,89.414,92.276" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="345.931" x="95.426,101.789,106.154,108.521,110.771,111.671,116.036,118.898,121.148,122.048,126.782,131.147,135.512,137.627,141.992,146.357,150.722,152.972,153.872,157.733,162.098,168.965,173.33,177.695,182.06,186.425,190.79,194.156,196.406,197.306,200.672,204.533,207.395,211.256,215.117,219.482,223.343,227.708,229.823,232.073,232.973,235.34,239.705,243.566,246.428,250.289,252.539,253.439,259.802,263.663,266.525,270.386,272.636,273.536,277.901,282.266,284.516,285.416,289.781,292.148,294.515,298.016" svgx:width="0.72,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.54,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.39,0.44,0.33,0.44,0.44,0.5,0.44,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Out of ~10,000 compounds screened, there were 21 hits </text>
   <text y="356.929" x="62.36,64.727,69.092,72.953,75.32,77.57,79.028,83.393,86.255,90.62,97.487,101.852,104.219,108.08,112.445,114.695,116.162,122.525,127.394,133.262,135.512,136.979,143.846,148.211,152.072,154.439,156.806,161.171,163.421,164.879,169.244,173.105,176.471,178.838,182.699,184.949,186.407,190.772,193.634,197.999,200.366,204.227,206.594,210.959,213.209,214.676,217.538,225.404,231.272,236.141,239.003,241.253,242.711,246.572,250.937,255.302,258.164,262.025,265.391,268.757,271.124,275.489,279.854,282.104,283.562,285.929,290.294,292.544,294.011,298.007" svgx:width="0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.78,0.5,0.28,0.44,0.5,0.25,0.55,0.72,0.56,0.67,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.39,0.28,0.44,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.33,0.89,0.67,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that promoted OPC myelin basic protein (MBP) expression in a </text>
   <text y="367.927" x="62.36,66.221,70.586,74.951,78.812,82.673,87.038,89.405,92.267,96.128,98.495,100.862,105.227,109.592,112.454,116.819,120.68,125.045,128.906,133.271,137.636,141.497,145.862,148.229,150.038,156.905,160.766,165.131,169.496,173.357,175.859,177.974,179.783,182.645,187.01,191.375,194.237,196.046,200.411,203.273,205.082,211.445,215.81,218.177,222.038,226.403,228.212,234.575,238.436,241.298,245.159,246.968,250.829,255.194,257.561,261.422,265.787,270.152,274.517,276.884,280.25,282.617,285.983,287.792,290.654,295.019,298.016" svgx:width="0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.33,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.78,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.33,0.5,0.5,0.33,0.25,0.5,0.33,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.28,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.39,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">concentration-dependent manner, four of which were antagonists for </text>
   <text y="378.925" x="62.36,64.727,69.092,72.953,75.203,76.913,83.276,85.643,88.01,92.375,95.237,99.098,103.463,107.828,112.193,114.56,118.421,122.786,125.036,126.746,129.608,133.469,137.33,141.191,145.556,147.923,152.288,155.15,157.4,159.11,163.475,165.842,169.208,171.575,175.436,182.303,184.67,189.035,192.896,195.146,196.856,203.219,207.584,209.834,211.544,214.406,218.267,222.128,225.989,230.354,232.721,237.086,239.948,242.198,243.908,246.77,253.133,257.498,263.366,266.228,268.343,270.593,272.303,277.172,281.537,284.399,286.766,291.131,294.992,297.989" svgx:width="0.28,0.5,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.33,0.44,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.28,0.44,0.78,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.33,0.72,0.5,0.67,0.33,0.25,0.25,0.55,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the Gi/o-coupled receptor histamine H3 receptor (H3R). Further </text>
   <text y="389.923" x="62.36,64.727,68.588,71.954,74.321,76.688,81.053,85.418,87.668,88.442,92.807,95.669,97.919,98.693,102.554,106.919,111.284,113.651,116.018,118.385,122.75,127.115,130.976,133.343,135.593,136.367,139.733,142.1,144.962,149.327,153.188,155.555,159.92,162.782,166.643,169.01,171.377,175.742,178.604,182.969,185.336,189.701,193.562,196.424,199.79,203.651,205.901,206.675,213.038,217.403,223.271,225.521,226.295,233.162,237.527,241.892,246.257,248.624,252.485,254.852,259.217,262.079,265.445,267.695,268.469,271.331,275.192,279.557,283.418,287.279,289.646,293.507,298.007" svgx:width="0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.33,0.5,0.28,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.72,0.5,0.67,0.25,0.55,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.33,0.44,0.5,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">testing of additional structurally-diverse H3R modulators revealed </text>
   <text y="400.921" x="62.36,64.727,69.092,72.953,75.32,77.876,82.241,86.606,88.973,93.338,95.894,98.261,102.626,106.991,110.852,113.714,117.08,120.941,123.497,127.358,131.723,136.088,140.453,142.82,146.186,148.553,151.919,154.475,158.84,163.205,165.572,168.128,172.493,176.858,179.225,181.781,186.146,190.007,194.372,196.739,199.601,203.462,205.829,208.385,212.246,216.611,218.978,222.839,227.204,231.569,235.934,238.301,241.667,244.034,247.4,249.956,254.321,257.183,261.548,268.415,272.78,275.147,279.008,283.373,285.929,290.294,292.661,295.028" svgx:width="0.28,0.5,0.44,0.28,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.44,0.5,0.28,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.39,0.25,0.5,0.33,0.5,0.78,0.5,0.28,0.44,0.5,0.25,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that only inverse agonists but not neutral antagonists promoted oli-</text>
   <text y="411.919" x="62.36,66.725,71.09,75.455,79.316,83.681,88.046,90.908,95.273,99.134,103.499,105.866,109.727,111.617,115.982,118.349,121.049,123.911,127.772,130.634,134.495,138.86,141.227,143.594,147.455,149.822,152.189,156.554,160.919,162.809,166.67,171.035,175.4,177.29,181.151,185.012,187.874,191.735,196.1,199.961,202.328,204.695,208.556,211.418,213.308,216.674,219.041,221.408,225.269,229.13,231.02,237.887,242.252,246.113,248.48,250.847,255.212,259.073,261.44,263.807,268.172,272.537,274.652,276.542,282.905,287.27,289.637,293.498,297.998" svgx:width="0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.33,0.44,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.39,0.28,0.28,0.44,0.44,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">godendrocyte differentiation and cerebellar slice myelination, which </text>
   <text y="422.917" x="62.36,64.727,71.594,75.959,78.326,80.693,84.554,88.919,91.169,92.447,96.308,98.558,99.836,104.201,108.062,112.427,114.677,115.955,118.817,123.182,125.549,129.41,131.66,132.938,137.303,140.165,142.415,143.693,146.06,150.425,154.286,156.536,157.814,161.675,166.04,170.405,173.771,176.138,178.505,180.872,185.237,187.604,189.971,194.336,198.197,200.447,201.725,205.586,209.447,211.814,214.181,218.546,220.913,223.28,227.645,229.895,231.173,235.538,238.4,240.65,241.928,248.291,252.656,258.524,260.639,262.889,264.167,270.53,274.895,280.763,283.013,284.291,290.654,294.515,298.016" svgx:width="0.28,0.78,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.5,0.67,0.25,0.25,0.55,0.72,0.5,0.67,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">implied a key role of the constitutive activity of H3R. H3R was </text>
   <text y="433.915" x="62.36,66.221,70.586,74.951,77.813,81.674,85.04,88.406,92.267,96.632,98.279,100.646,105.011,106.658,110.519,112.886,115.253,116.9,120.266,122.633,126.494,130.859,134.72,138.086,139.733,144.098,146.96,148.607,152.972,155.339,157.706,162.071,166.436,170.801,174.662,179.027,183.392,186.254,190.619,194.48,198.845,201.212,205.073,206.72,211.085,213.452,216.152,219.014,222.875,225.737,229.598,233.963,236.33,238.697,242.558,244.925,247.292,251.657,256.022,258.137,259.784,263.645,268.01,272.375,274.022,277.388,279.755,285.623,291.986,297.989" svgx:width="0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.39,0.28,0.44,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.39,0.28,0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">expressed in all stages of oligodendrocyte differentiation, and siRNA </text>
   <text y="444.913" x="62.36,66.725,71.09,75.455,79.316,83.681,86.543,90.908,95.273,101.636,106.001,108.044,112.409,115.271,117.314,123.677,128.042,133.91,135.953,139.814,144.179,148.544,151.406,155.267,158.633,161.999,164.366,168.731,173.096,175.139,177.506,181.871,183.905,188.639,193.004,197.369,204.731,206.765,211.13,213.992,216.035,220.4,224.765,227.627,234.494,238.355,240.722,242.756,245.123,248.984,253.349,257.21,259.577,262.943,264.977,268.838,273.203,277.568,281.429,285.794,289.655,293.516,298.016" svgx:width="0.5,0.5,0.5,0.44,0.5,0.33,0.5,0.5,0.72,0.5,0.25,0.5,0.33,0.25,0.72,0.5,0.67,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.54,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">knock-down of H3R expression to ~40% of normal levels enhanced </text>
   <text y="455.911" x="62.36,64.727,69.092,72.953,75.149,79.01,83.375,87.74,90.602,94.463,97.829,101.195,103.562,107.927,112.292,114.488,118.853,121.715,123.911,131.777,137.645,142.181,144.377,148.238,152.603,156.968,159.164,166.031,170.396,174.257,176.624,178.991,183.356,185.552,189.413,192.779,196.145,200.51,204.371,206.738,210.599,212.966,216.827,221.192,223.388,227.753,230.12,234.485,238.346,242.711,247.076,249.938,254.303,256.67,260.531,262.898,267.263,269.459,272.321,280.187,286.55,292.913,295.775,298.025" svgx:width="0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.89,0.67,0.56,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.44,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.33,0.89,0.72,0.72,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the expression of MBP and myelin associated glycoprotein (MAG), </text>
   <text y="466.909" x="62.36,69.227,73.088,75.95,80.315,84.176,87.038,90.404,92.159,95.021,99.386,102.248,104.003,110.87,114.731,117.098,121.463,124.325,128.186,129.941,134.306,136.673,139.04,143.405,147.77,152.135,155.996,160.361,164.726,167.588,171.953,175.814,180.179,182.546,186.407,189.773,191.888,193.643,198.512,202.877,205.739,208.106,212.471,216.332,219.194,226.061,230.426,233.288,237.149,239.264,241.019,244.385,248.75,252.116,254.483,258.344,265.211,267.578,271.439,273.194,277.055,281.42,288.287,290.654,295.019" svgx:width="0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.33,0.5,0.33,0.25,0.78,0.44,0.28,0.5,0.33,0.44,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.28,0.44,0.25,0.44,0.5,0.78,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">markers for mature oligodendrocytes. Furthermore, systemic admin-</text>
   <text y="477.907" x="62.36,64.727,68.093,70.46,73.322,77.183,79.55,81.917,86.282,90.647,92.897,94.463,98.828,101.69,103.94,105.506,109.367,111.617,113.183,117.548,120.41,124.271,126.638,131.003,133.865,138.23,142.091,146.456,150.317,152.684,155.546,159.407,163.772,166.139,170.0,172.25,173.816,180.179,184.544,190.412,192.662,194.228,196.595,200.96,205.325,209.186,212.048,215.414,219.275,221.525,223.091,226.952,231.317,235.682,240.047,242.414,245.78,248.147,250.262,252.512,254.078,260.441,265.31,271.673,276.038,280.403,284.768,289.133,293.498,297.998" svgx:width="0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.44,0.5,0.44,0.28,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.72,0.5,0.67,0.25,0.55,0.28,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.25,0.55,0.72,0.56,0.72,0.5,0.5,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">istration of a brain-penetrable H3R inverse agonist, GSK247246 </text>
   <text y="488.905" x="62.36,66.221,70.586,74.951,78.812,83.177,87.038,90.899,95.264,97.874,100.736,104.597,111.464,115.829,119.69,122.057,124.424,128.789,132.65,135.017,137.384,141.749,146.114,148.724,151.091,155.456,158.066,160.433,164.798,168.659,171.269,178.136,182.501,186.866,190.232,194.093,196.703,200.564,204.929,209.294,212.156,214.523,218.384,222.749,227.114,230.975,233.585,240.452,244.817,249.182,253.043,255.41,257.525,259.973,265.337,269.702,273.563,276.929,280.79,283.4,287.765,291.626,293.993,297.989" svgx:width="0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.5,0.39,0.44,0.25,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.44,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.25,0.61,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enhanced remyelination in the mouse cuprizone model. These data </text>
   <text y="499.903" x="62.36,65.726,70.091,74.456,78.821,83.186,86.048,88.415,90.233,92.6,96.965,100.826,103.193,105.02,107.387,111.752,115.613,117.431,121.292,125.657,130.022,133.388,135.755,138.122,140.489,144.854,147.221,149.588,153.953,157.814,159.632,163.493,167.354,169.721,172.088,176.453,178.82,181.187,185.552,187.37,191.735,194.597,196.424,202.787,207.152,213.02,214.847,219.212,223.073,227.438,231.299,233.666,236.033,240.398,244.259,246.626,250.991,252.818,255.68,259.541,263.906,268.271,270.638,274.499,276.866,280.727,284.093,285.92,290.285,292.652,295.019" svgx:width="0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.72,0.5,0.67,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">support that the constitutive activity of H3R negatively regulates oli-</text>
   <text y="510.901" x="62.36,66.725,71.09,75.455,79.316,83.681,88.046,90.908,95.273,99.134,103.499,105.866,109.727,112.427,116.792,119.159,121.859,124.721,128.582,131.444,135.305,139.67,142.037,144.404,148.265,150.632,152.999,157.364,161.729,163.844,166.544,169.406,173.771,176.471,180.836,185.201,192.068,195.929,200.294,203.66,205.775,208.475,214.838,218.699,221.399,225.764,229.625,231.992,235.853,239.714,242.081,245.942,250.307,253.007,257.372,259.739,262.106,266.471,270.836,275.201,279.062,283.427,287.792,290.654,295.019" svgx:width="0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.33,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.39,0.25,0.25,0.72,0.44,0.25,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">godendrocyte differentiation. In humans, we detected oligodendro-</text>
   <text y="521.899" x="62.36,66.725,69.092,71.459,75.32,77.687,79.937,81.692,88.055,92.42,98.288,100.538,102.293,106.154,110.519,114.884,117.746,121.607,124.973,128.339,130.706,135.071,139.436,141.686,143.441,145.808,150.173,152.423,154.178,158.543,162.404,169.271,173.636,177.497,179.864,182.231,186.596,190.457,192.824,196.685,201.05,203.3,205.055,212.921,217.79,220.04,221.795,224.162,228.023,231.389,233.756,238.121,242.486,245.852,248.102,249.857,253.718,258.083,262.448,264.698,266.453,270.818,275.183,278.549,282.41,285.272,289.637,293.498,297.998" svgx:width="0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.72,0.5,0.67,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">glial H3R expression in demyelinated MS lesions and observed </text>
   <text y="532.897" x="62.36,66.725,70.586,74.951,78.812,81.179,83.546,87.407,89.657,90.611,94.472,97.838,101.204,105.569,109.43,111.797,115.658,118.025,120.392,124.757,129.122,131.372,132.326,136.691,140.552,142.919,149.282,153.143,157.004,161.369,163.619,164.573,168.434,172.799,175.049,176.003,179.864,184.229,188.594,192.959,195.326,199.187,201.437,202.391,205.757,208.124,212.489,216.854,219.221,223.082,225.332,226.286,230.651,235.016,238.877,241.244,245.105,249.47,251.837,254.204,258.569,262.43,264.68,265.634,269.999,274.364,276.731,281.096,287.963,292.328,295.019" svgx:width="0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.44,0.28,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.78,0.5,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">genetic association between an exonic single nucleotide polymor-</text>
   <text y="543.895" x="62.36,66.725,71.09,73.457,76.823,83.69,85.94,88.145,90.512,94.877" svgx:width="0.5,0.5,0.28,0.39,0.78,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phism in </text>
   <text y="543.895" x="99.332,105.695,111.059,117.422,121.787" svgx:width="0.72,0.61,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">HRH3 </text>
   <text y="543.895" x="126.233,130.094,134.459,138.824,141.074,143.279,146.645,151.01,154.376,158.237,162.098,166.463,168.83,171.197,175.562,177.929,180.296,182.663,185.03,189.395,191.645,193.85,196.217,200.582,202.832,205.037,212.903,217.772,220.022,222.227,225.089,229.454,234.395,238.76,240.875,245.24,249.605,253.97,256.085,258.335,260.54,266.903,272.771,277.712,282.077,284.192,288.557,292.922,295.784,298.034" svgx:width="0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.39,0.44,0.44,0.5,0.28,0.28,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.72,0.67,0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and susceptibility to MS (p=0.006, OR=1.22). </text>
   <text y="554.893" x="62.36,68.723,73.592,79.955,84.32,88.685,93.05,97.415,101.78,106.145,108.395,109.718,112.085,115.451,117.701,119.024,122.885,125.135,126.458,130.823,133.19,137.555,141.92,144.287,148.652,150.902,152.225,156.59,160.955,163.322,167.183,171.548,173.915,176.03,178.28,179.603,182.969,186.83,189.197,193.058,196.919,199.286,201.653,206.018,209.879,211.994,214.244,215.567,219.932,222.794,226.655,229.022,231.389,235.754,238.004,239.327,243.692,246.059,250.424,254.285,258.65,262.511,264.878,267.245,271.106,275.471,277.838,281.699,283.949,285.272,289.133,293.498,297.998" svgx:width="0.72,0.56,0.72,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.25,0.55,0.39,0.44,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.33,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GSK239512 is a highly potent, selective, orally bioavailable and </text>
   <text y="565.891" x="62.36,66.725,69.587,73.448,75.815,80.18,82.16,86.525,90.386,94.751,98.612,100.979,103.841,107.702,112.067,114.434,116.414,122.777,127.142,129.122,131.984,135.845,139.706,143.567,147.932,150.299,154.664,157.526,159.506,161.873,166.238,170.603,174.464,177.326,180.692,184.553,186.533,190.394,194.759,199.124,203.489,205.856,209.222,211.589,213.569,219.932,222.299,224.666,229.031,231.011,234.872,236.852,241.217,245.582,249.947,254.312,256.292,259.658,263.519,266.381,270.242,272.609,276.974,279.341,281.708,286.073,288.44,292.301,295.019" svgx:width="0.5,0.33,0.44,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.33,0.44,0.5,0.28,0.25,0.72,0.5,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.28,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.28,0.28,0.5,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">brain penetrant H3 receptor inverse agonist with a good safety/toler-</text>
   <text y="576.889" x="62.36,66.221,70.586,72.953,75.32,77.687,80.054,84.419,86.669,92.015,96.38,99.242,103.607,106.469,108.836,111.203,115.064,117.431,119.681,125.027,131.39,135.755,139.616,143.981,146.231,151.577,153.944,157.805,161.171,163.538,167.399,171.764,174.014,179.36,181.727,186.092,188.342,193.688,200.555,204.92,208.781,211.148,213.515,217.88,221.741,224.108,226.475,230.84,235.205,238.067,240.929,244.79,247.157,251.018,255.383,259.244,263.609,265.976,268.226,273.572,277.433,280.799,284.165,288.026,292.391,295.757,298.007" svgx:width="0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.28,0.25,0.55,0.72,0.5,0.44,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.33,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ability profile; when tested in myelination-relevant assays, </text>
   <text y="587.887" x="62.36,68.723,73.592,79.955,84.32,88.685,93.05,97.415,101.78,106.145,108.098,112.463,116.324,123.191,127.556,131.921,135.287,137.654,140.516,144.377,146.744,150.605,154.97" svgx:width="0.72,0.56,0.72,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">GSK239512 demonstrated </text>
   <text y="587.887" x="156.923,159.29,163.655,165.608,169.469,171.836,174.203,177.236" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="587.887" x="181.601,183.554,187.415,191.78,196.145" svgx:width="0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> and </text>
   <text y="587.887" x="198.098,200.465,204.83,206.783,210.644,213.011,216.872" svgx:width="0.28,0.5,0.25,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vivo</text>
   <text y="587.887" x="221.237,223.19,227.051,229.751,232.613,234.98,238.841,242.702,246.563,250.928,252.881,255.248,259.613,261.566,265.931,268.793,273.158,280.025,284.39,286.757,289.124,293.489,297.989" svgx:width="0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.33,0.5,0.78,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> efficacy in promoting </text>
   <text y="598.885" x="62.36,66.725,69.092,71.459,75.824,80.189,84.554,88.415,92.78,97.145,100.007,104.372,108.233,112.598,114.965,118.826,120.941,125.306,127.673,130.373,133.235,137.096,139.958,143.819,148.184,150.551,152.918,156.779,159.146,161.513,165.878,170.243,172.358,176.219,180.584,184.949,187.064,193.931,198.296,202.157,204.524,206.891,211.256,215.117,217.484,219.851,224.216,228.581" svgx:width="0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">oligodendrocyte differentiation and myelination.</text>
   <text y="609.883" x="62.36,68.858,73.358,78.362,82.358,84.86,89.864,93.365,95.867,100.367,105.371,108.872,111.869" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="609.883" x="113.732,118.736,121.733,126.233,133.235,135.098,139.598,144.098,148.094,152.594,157.094,159.596,164.096,168.596,171.098,175.094,176.957,180.458,184.454,187.451,191.447,195.443,199.943,201.806,204.308,208.808,210.671,215.171,219.671,226.673,230.669,235.169,237.032,241.532,245.528,250.028,254.024,256.526,259.028,263.024,266.525,268.775,270.638,277.136,281.132,282.995,287.495,290.492,294.992" svgx:width="0.56,0.33,0.5,0.78,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.39,0.44,0.33,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.78,0.44,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">From phenotypic screen to human genetics, we pro-</text>
   <text y="620.881" x="62.36,66.86,69.362,73.862,77.858,80.495,84.491,88.991,91.493,95.993,99.989,104.489,108.485,112.481,115.118,118.115,122.615,125.612,128.249,134.747,139.247,145.25,147.887,151.883,155.384,158.021,162.017,164.654,169.154,173.654,178.154,182.15,184.652,187.289,189.791,194.291,198.287,201.284,205.28,209.78,213.776,218.276,220.778,223.28,227.276,229.913,232.415,236.411,239.246,243.746,247.742,250.244,252.881,255.878,260.378,263.375,266.012,273.014,277.514,281.51,284.012,286.514,291.014,295.01" svgx:width="0.5,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.33,0.25,0.72,0.5,0.67,0.25,0.44,0.39,0.25,0.44,0.25,0.5,0.5,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.33,0.5,0.33,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vide evidence for H3R as a novel therapeutic target for myelina-</text>
   <text y="631.879" x="62.36,64.862,67.364,71.864,76.364,78.614,80.648,85.148,89.144,93.644,96.146,100.646,105.146,107.18,109.682,114.182,118.178,120.212,126.71,130.706,135.206,137.24,140.237,144.737,147.734,149.768,153.764,156.266,158.768,163.268,165.77,169.766,173.762,176.264,178.298,180.8,184.796,188.297,190.799,193.301,197.801,202.301,204.335,208.835,211.832,213.866,220.364,225.368,231.866,236.366,240.866,245.366,249.866,254.366,258.866,260.9,263.402,267.902,269.936,277.937,282.941,284.975,288.971,293.471,297.971" svgx:width="0.28,0.28,0.5,0.5,0.25,0.25,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.56,0.72,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion, paving the way for clinical testing of GSK239512 in MS and </text>
   <text y="642.877" x="62.36,66.86,69.362,73.862,77.858,80.855,83.105,87.605,91.601,98.603,103.103,107.099,109.601,112.103,116.603,120.599,123.101,125.603,130.103,134.603,136.853,141.353,143.855,147.356,151.352,155.348,158.849,162.845,166.346" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other demyelinating diseases.</text>
   <text y="669.877" x="62.36,67.859,72.359,76.859" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P622</text>
   <text y="680.875" x="62.36,67.859,71.855,76.355,80.351,84.347,91.844,96.344,100.34,102.842,105.344,110.348,114.848,117.845,120.347,125.351,129.851,132.101,137.105,141.101,145.601,150.605,154.601,158.597,161.594,164.096,168.092,171.593,173.843,178.343,181.34,183.59,188.594,192.59,197.594,201.59,206.09,209.087,211.589,214.091,218.591,226.088,230.084,235.088,238.085,240.335,245.339,249.335,254.339,257.336,259.838,264.842,268.838" svgx:width="0.61,0.44,0.5,0.44,0.44,0.83,0.5,0.44,0.28,0.28,0.56,0.5,0.33,0.28,0.56,0.5,0.25,0.56,0.44,0.5,0.56,0.44,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.56,0.44,0.56,0.44,0.5,0.33,0.28,0.28,0.5,0.83,0.44,0.56,0.33,0.25,0.56,0.44,0.56,0.33,0.28,0.56,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Proremyelinating properties of neurofilament peptide </text>
   <text y="691.873" x="62.36,68.858,74.357,80.36,83.357,89.36,95.363,100.367,102.617,107.117,111.617,114.614,119.114,123.614,125.864,130.364,135.368,140.372,142.622,147.122,151.622,156.122,161.126,163.376,167.372,171.872,174.869,179.369,182.87,187.874,191.87,194.372,198.368,201.365,205.865,210.869,213.119,218.123,222.119,226.619,229.616,233.612,236.114,241.118,244.619" svgx:width="0.72,0.61,0.67,0.33,0.67,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.5,0.56,0.56,0.25,0.5,0.5,0.5,0.56,0.25,0.44,0.5,0.33,0.5,0.39,0.56,0.44,0.28,0.44,0.33,0.5,0.56,0.25,0.56,0.44,0.5,0.33,0.44,0.28,0.56,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">NFL-TBS.40-63 and axon cytoskeleton proteins </text>
   <text y="691.873" x="246.869,249.371,253.871,256.121,260.117,262.619,265.121,268.622" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="702.871" x="62.36,68.363,70.613,75.617,78.614,82.61,86.111,89.612,92.114,96.614,100.61,105.11" svgx:width="0.67,0.25,0.56,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">C Fressinaud</text>
   <text y="700.439" x="109.612,112.537,113.999" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1,2</text>
   <text y="702.959" x="116.924,119.174,121.424,124.925,127.175,132.674,137.174,141.17" svgx:width="0.25,0.25,0.39,0.25,0.61,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Eyer</text>
   <text y="700.439" x="144.167" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="711.437" x="62.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="713.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,111.529,116.029,119.53,124.03,126.532,129.034,133.534,136.036,138.286,140.536,146.539,150.535,155.035,158.536,163.036,165.538,170.038,174.538,178.534,180.784,187.282,191.278,195.778,200.278,203.779,206.281,212.779,216.775,221.275,223.777,226.027,228.277,233.776,238.276,242.776,246.772,250.273,253.774,256.024,258.274,263.773,267.274,271.774,276.274,280.27,284.266,286.516" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.5,0.44,0.39,0.39,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital, Neurology Department, Angers, France, </text>
   <text y="722.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="724.959" x="65.287,70.291,76.789,82.792,88.291,95.788,98.038,100.288,106.786,112.285,117.784,123.283,127.783,130.033,135.532,141.031,143.281,147.781,152.281,156.781,161.281,163.531,165.781,171.28,175.78,180.28,184.276,187.777,191.278,193.528,195.778,201.277,204.778,209.278,213.778,217.774" svgx:width="0.56,0.72,0.67,0.61,0.83,0.25,0.25,0.72,0.61,0.61,0.61,0.5,0.25,0.61,0.61,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.5,0.44,0.39,0.39,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">LUNAM, UPRES EA 3143, Angers, France</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 567.160 L355.760 567.160 "/>
  <g begin="text">
   <text y="76.959" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="76.959" x="363.125,369.623,374.123,378.623,383.123,385.886,390.386,394.382,398.882,401.879,406.379,409.376,411.878,414.38,418.376,425.378,429.374,433.874,436.376,439.877,442.64,445.637,452.135,457.139,460.136,462.899,466.895,469.892,473.888,476.651,480.647,483.149,485.651,489.647,492.644,496.64,501.14,503.903,506.405,510.905,513.668,518.168,522.164,529.166,533.666,537.662,540.164,542.666" svgx:width="0.72,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.33,0.28,0.28,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.56,0.33,0.25,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Axon neurofilaments (NF) are altered in demyeli-</text>
   <text y="87.957" x="310.016,314.516,318.512,321.014,325.01,329.51,331.76,334.442,338.942,341.444,345.44,349.94,354.44,358.436,361.937,364.187,366.869,369.371,373.871,376.121,378.803,386.804,391.808,394.058,396.308,398.99,402.986,407.486,411.986,414.236,416.918,419.42,423.92,427.916,430.166,432.848,436.844,441.344,445.844,449.84,453.836,458.336,460.838,463.835,467.831,470.333,472.835,477.335,481.835,484.085,486.767,491.267,494.264,496.514,499.196,505.694,510.698,512.948,515.63,519.131,523.631,528.131,532.631,537.131,539.633,542.135,545.636" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.25,0.55,0.39,0.5,0.5,0.5,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nated plaques in MS, and the concentration of NF subunits </text>
   <text y="98.955" x="310.016,313.013,317.009,319.511,323.507,327.503,331.004,335.0,339.5,341.813,344.315,348.815,351.137,353.639,358.139,362.135,364.448,370.451,375.455,380.459,382.772,386.768,391.268,394.265,397.262,401.258,403.76,407.756,410.258,414.254,417.755,420.068,426.566,429.068,431.57,436.07,438.383,442.883,445.385,448.886,452.882,456.878,460.379,464.375,466.688,470.189,474.185,478.685,482.681,485.678,488.18,490.682,494.597,496.847,499.169,505.667,509.663,514.163,518.159,521.156,523.658,528.158,532.154,534.656,538.652,542.153,545.654" svgx:width="0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.56,0.56,0.25,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.25,0.72,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.28,0.44,0.39,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">released in the CSF correlates with disease severity. Nevertheless </text>
   <text y="109.953" x="310.016,312.518,317.018,321.014,323.264,323.948,326.945,331.445,333.947,337.943,340.193,340.886,345.386,348.383,350.633,351.317,357.815,362.819,365.069,365.753,368.255,372.755,375.005,375.698,378.2,382.7,386.696,388.946,389.63,393.626,398.126,400.628,403.625,407.621,411.617,416.117,420.617,425.117,429.113,431.615,433.865,434.549,437.051,441.551,445.547,449.543,452.045,454.547,459.047,463.547,465.797,466.481,468.983,472.484,474.734,475.418,479.918,484.418,488.918,493.418,497.918,504.416,508.916,511.166,513.947,521.723,525.719,527.969,528.653,533.153,537.149,541.649,545.645" svgx:width="0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.33,0.44,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.72,0.5,0.25,0.25,0.94,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the role of NF in the extraaxonal location is unknown. We have </text>
   <text y="120.951" x="310.016,314.516,318.512,325.514,330.014,334.514,338.015,340.517,343.514,347.51,350.012,354.008,358.508,360.758,361.46,363.962,368.462,372.458,374.96,377.21,377.912,384.41,389.414,391.664,392.366,396.362,400.862,405.362,407.612,408.314,410.816,415.316,419.816,424.316,426.818,429.32,433.82,436.07,436.772,439.769,443.765,447.266,451.262,455.762,459.758,462.008,462.71,467.21,469.712,472.214,476.714,481.214,485.714,489.71,494.21,498.71,501.707,506.207,510.203,514.703,517.205,521.201,524.702,526.952,527.654,530.651,537.149,542.648,545.645" svgx:width="0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.44,0.5,0.44,0.25,0.55,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.72,0.61,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demonstrated that NF and tubulin rescue oligodendrocytes (OL) </text>
   <text y="131.949" x="310.016,313.013,316.01,320.51,327.512,329.762,334.811,337.313,341.813,346.313,348.815,352.811,355.061,360.11,364.61,368.606,375.608,380.108,384.104,386.606,389.108,393.608,397.604,400.106,402.608,407.108,411.608" svgx:width="0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">from toxic demyelination </text>
   <text y="131.949" x="418.907,421.409,425.909,428.159,433.208,437.204,439.706,442.208,445.376" svgx:width="0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="131.949" x="449.876,452.126,457.175,460.172,465.176,468.173,472.169,475.67,479.171,481.673,486.173,490.169,494.669,499.169,501.419,506.468,510.464,514.964,519.464,521.714,526.763,532.262,536.762,540.758,543.395,545.645" svgx:width="0.25,0.55,0.33,0.56,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.5,0.44,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> (Fressinaud and Eyer, </text>
   <text y="142.947" x="310.016,316.514,320.51,325.01,328.007,332.507,336.503,341.003,344.999,352.001,354.251,357.248,361.748,364.25,366.5,368.75,373.25,377.75,382.25,386.75,389.0,391.25,395.75,400.25,402.752,407.252,411.752,416.252,419.249,423.749,428.249,431.246" svgx:width="0.72,0.44,0.5,0.33,0.5,0.44,0.5,0.44,0.78,0.25,0.33,0.5,0.28,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neurochem Int. 2013, 62:306-13).</text>
   <text y="153.945" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="153.945" x="356.555,363.053,366.554,368.804,369.605,376.103,381.107,383.357,384.158,388.154,391.151,395.147,397.397,398.198,400.7,403.202,407.702,411.698,414.2,418.7,420.95,421.751,425.252,429.752,434.252,441.254,443.756,446.258,448.76,452.756,457.256,459.506,460.307,462.809,467.309,469.559,470.36,474.86,477.857,482.357,484.859,488.855,493.355,495.857,500.357,503.858,506.36,509.861,512.111,514.361,515.162,521.66,525.656,527.906,528.707,533.207,537.203,541.703,545.699" svgx:width="0.72,0.39,0.25,0.55,0.72,0.56,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.78,0.28,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.72,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As NF are likely submitted to proteolysis, we have </text>
   <text y="164.943" x="310.016,314.012,318.512,322.508,325.01,329.51,333.506,337.502,342.002,344.666,347.168,350.165,352.838,356.339,360.839,365.339,367.841,372.341,376.337,378.839,381.341,385.337,388.001,392.501,396.497,400.997,403.499,406.001,410.501,414.497,417.998,420.662,424.658,429.158,432.155,435.152,439.148,442.649,447.149,451.649,456.149,460.649,463.151,467.651,472.151,474.815,477.317,481.817,484.49,486.992,491.492,495.488,498.161,500.663,505.163,509.663,514.163,516.665,519.167,523.667,526.664,531.164,533.666,538.166,542.666" svgx:width="0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.28,0.33,0.25,0.39,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.25,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.39,0.25,0.44,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.33,0.5,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">analyzed if synthetic peptides corresponding to the tubulin-bind-</text>
   <text y="175.941" x="310.016,312.518,317.018,321.518,323.768,326.207,329.708,332.21,334.712,338.708,340.958,343.397,346.394,351.893,357.896,362.9,365.897,368.147,370.586,374.087,378.083,382.583,387.083,391.079,395.579,399.575,403.571,405.821,408.26,410.762,415.262,419.258,423.758,426.26,428.762,431.759,434.261,438.257,442.757,445.007,447.446,451.946,456.446,458.696,461.135,463.637,466.139,470.639,475.139,477.641,479.891,482.33,488.828,493.832,496.082,498.521,502.517,507.017,511.013,513.515,518.015,520.265,522.704,525.701,532.199,537.203,542.702" svgx:width="0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.28,0.44,0.25,0.55,0.33,0.61,0.67,0.56,0.33,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.72,0.56,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.25,0.55,0.33,0.72,0.56,0.61,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing site (TBS) sequence identified on light NF chain (NFL-</text>
   <text y="186.939" x="310.016,315.515,321.518,326.522,328.772,333.272,337.772,340.769,345.269,349.769,352.766,355.016,359.012,363.512,368.012,370.514,375.014,377.264,380.261,384.257,388.757,393.257,395.759,399.755,402.257,406.253,408.503,415.001,420.167,422.417,425.414,429.41,431.912,435.908" svgx:width="0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.72,0.61,0.25,0.33,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TBS.40-63) could regulate OL fate </text>
   <text y="186.939" x="438.158,440.66,445.16,447.41,451.406,453.908,456.41,459.578" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="186.939" x="464.078" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">.</text>
   <text y="197.937" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="197.937" x="350.705,355.709,360.209,363.206,367.202,369.452,371.396,374.393,378.389,380.891,383.141,385.085,391.583,396.749,398.999,400.943,404.939,409.439,413.939,416.189,418.133,422.129,425.63,428.132,431.129,435.629,439.625,444.125,446.627,450.623,452.873,454.817,457.814,464.312,469.316,472.313,474.563,476.507,480.503,485.003,487.505,490.007,494.507,497.504,501.5,505.001,507.251,509.501,511.445,515.945,518.942,523.442,529.94,534.44,536.69,538.634,541.136,545.636" svgx:width="0.56,0.5,0.33,0.44,0.25,0.55,0.33,0.44,0.28,0.25,0.55,0.72,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.72,0.56,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.39,0.25,0.25,0.55,0.5,0.33,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Pure rat OL and astrocyte (AS) cultures, grown in </text>
   <text y="208.935" x="310.016,314.012,318.512,322.508,329.51,332.012,336.008,340.004,342.506,345.008,349.508,352.505,357.005,361.001,363.998,366.5,371.0,374.996,379.496,382.115,389.117,393.113,397.613,400.115,404.615,411.617,414.236,420.734,424.73,427.727,431.723,434.342,436.844,439.841,443.837,447.833,450.335,454.331,458.831,461.45,467.948,470.45,472.952,477.452,480.071,484.571,487.073,491.573,494.075,496.577,501.077,505.577,508.079,512.075,514.577,518.573,523.073,525.692,532.19,537.194,542.693" svgx:width="0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.28,0.5,0.33,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.78,0.44,0.5,0.28,0.5,0.78,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.56,0.61,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">chemically-defined medium were treated with biotinylated NFL-</text>
   <text y="219.933" x="310.016,315.515,321.518,326.522,328.772,333.272,337.772,340.769,345.269,349.769,352.019,356.978,359.975,366.473,371.477,376.481,382.979,387.983,394.481,399.485,405.983,410.987,415.991,420.995,426.494,431.498,437.996,443.999,450.002,455.006,461.504,466.508,471.512,476.516,481.52,488.018,493.022,496.019,498.269,500.519,505.469,509.465,513.965,518.465,520.715,525.674,532.172,537.176,542.675" svgx:width="0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.33,0.72,0.56,0.56,0.72,0.56,0.72,0.56,0.72,0.56,0.56,0.56,0.61,0.56,0.72,0.67,0.67,0.56,0.72,0.56,0.56,0.56,0.56,0.72,0.56,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.56,0.61,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TBS.40-63 (YSSYSAPVSSSLSVRRSYSSSSGS), and NFL-</text>
   <text y="230.931" x="310.016,313.517,317.513,320.51,324.506,331.508,336.008,338.51,342.506,344.756,346.241,350.741,354.737,359.237,361.739,364.241,368.741,372.737,374.987,376.481,379.478,385.976,390.98,396.479,399.476,404.48,410.483,416.486,420.986,423.983,426.233,427.718,434.216,436.718,439.22,443.72,445.97,447.455,449.957,454.457,458.453,460.703,462.197,465.698,469.694,476.696,480.692,482.942,484.427,488.423,495.425,497.927,502.427,506.927,509.924,513.92,517.916,520.418,524.918,528.419,530.669,532.154,534.656,539.156,543.152,545.654" svgx:width="0.39,0.44,0.33,0.44,0.78,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.72,0.56,0.61,0.33,0.56,0.67,0.67,0.5,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.78,0.44,0.25,0.55,0.44,0.78,0.28,0.5,0.5,0.33,0.44,0.44,0.28,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">scramble peptide (NFL-SCR2) with the same amino-acids that </text>
   <text y="241.929" x="310.016,316.514,321.518,327.017,330.014,335.513,341.516,346.52,348.77,353.27,357.77,360.767,365.267,369.767,372.017,374.267,375.626,379.622,382.124,384.626,389.126,393.626,398.126,402.626,407.126,409.376,410.735,413.237,417.737,419.987,421.346,424.343,428.339,432.839,437.339,441.839,448.841,451.091,452.45,455.951,459.947,464.447,468.947,472.943,477.443,481.439,485.435,487.685,489.044,492.041,496.541,501.041,503.291,504.65,509.474,517.475,519.725,521.975,523.334,527.834,532.334,534.584,535.943,540.443,543.44,545.69" svgx:width="0.72,0.56,0.61,0.33,0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.25,0.55,0.44,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.54,0.89,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NFL-TBS.40-63, although in random sequence (10 ÂµM, 24 h). </text>
   <text y="252.927" x="310.016,315.02,318.017,322.517,325.019,327.521,330.518,334.514,337.511,341.507,344.009,346.511,351.011,355.511,357.662,361.658,366.158,370.658,372.809,377.309,379.811,382.646,385.643,389.639,392.636,396.632,401.132,403.634,406.136,410.132,412.634,415.136,419.636,424.136,426.287,432.785,436.781,439.778,443.774,445.925,449.921,454.421,458.417,461.414,465.41,469.406,471.908,475.904,478.901,481.403,485.399,489.395,493.895,496.037,500.537,504.038,506.54,511.04,515.54,517.691,521.192,525.692,529.688,533.684,536.186,539.183,541.685,545.681" svgx:width="0.56,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Proliferation and differentiation were characterized using specific </text>
   <text y="263.925" x="310.016,314.012,318.512,321.014,323.516,328.016,332.516,337.016,339.518,343.514,347.015,349.265,351.272,354.269,356.771,361.271,363.521,365.528,370.028,373.025,377.525,384.527,389.027,393.527,397.523,402.023,406.523,411.023,415.523,418.52,421.022,425.522,428.024,432.524,436.52,438.77,441.02,442.532,449.03,453.53,459.533,464.033,466.283,468.533,470.54,476.543,483.041,487.046,489.296,491.546,493.553,501.554,507.557,511.562,513.812,516.062,518.069,524.567,528.905,535.403,540.407,543.404,545.654" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.78,0.5,0.5,0.44,0.5,0.5,0.5,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.25,0.55,0.72,0.5,0.67,0.5,0.25,0.25,0.55,0.67,0.72,0.56,0.25,0.25,0.55,0.89,0.67,0.56,0.25,0.25,0.55,0.72,0.56,0.72,0.56,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibodies (to bromodeoxyuridine, A2B5, CNP, MBP, GFAP), </text>
   <text y="274.923" x="310.016,314.012,318.512,323.012,325.262,329.258,333.758,340.76,345.26,349.256,352.253,356.249,360.749,362.999,365.501,370.001,372.251,376.751,381.251,383.753,386.75,390.746,394.742,397.244,401.24,405.74,407.99,411.986,416.486,420.986,423.488,426.485,430.985,433.487,435.737,439.733,444.233,446.735,449.237,453.737,456.734,460.73,464.231" svgx:width="0.44,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and compared to untreated control cultures.</text>
   <text y="285.921" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="285.921" x="343.802,350.3,355.304,360.803,363.8,369.299,375.302,380.306,382.556,387.056,391.556,394.553,399.053,403.553,406.343,409.844,412.346,416.846,421.346,423.848,426.845,429.347,433.343,437.339,441.839,444.341,446.843,451.343,454.133,456.635,461.135,465.131,468.128,472.124,476.12,479.621,483.617,488.117,490.907,497.405,502.571,505.361,509.861,512.363,515.198,518.195,522.191,525.188,529.184,533.684,536.186,538.688,542.684" svgx:width="0.72,0.56,0.61,0.33,0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.72,0.61,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NFL-TBS.40-63 significantly increased OL differentia-</text>
   <text y="296.919" x="310.016,312.518,315.02,319.52,324.02,326.603,330.599,335.099,339.599,342.173,349.175,353.171,355.673,360.173,363.17,367.166,369.668,372.17,376.67,381.17,383.744,390.242,392.744,395.246,399.746,402.32,409.322,413.822,416.819,420.815,423.398,429.401,435.899,440.903,445.979,448.553,452.549,457.049,461.549,464.123,472.124,478.127,483.131,488.207,490.79,494.786,498.782,501.284,503.786,507.287,509.861,513.857,518.357,522.353,525.35,529.346,533.342,535.844,539.84,542.675" svgx:width="0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.33,0.44,0.25,0.67,0.72,0.56,0.56,0.25,0.44,0.5,0.5,0.25,0.89,0.67,0.56,0.56,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion and maturation with more CNP+ and MBP+ cells character-</text>
   <text y="307.917" x="310.016,312.518,316.514,320.51,325.01,327.845,332.345,336.845,339.68,344.18,348.68,355.682,359.678,362.675,367.175,371.675,375.176,378.011,381.008,385.004,392.006,394.508,397.505,400.007,404.003,408.503,411.338,415.838,418.835,423.335,427.331,431.327,434.828,438.329,442.325,445.826,448.076,450.911,454.907,459.407,463.907,466.742,471.242,475.742,478.244,482.24,484.742,487.244,491.744,495.74,498.575,505.577,510.077,514.073,516.575,519.077,523.577,526.412,530.912,534.908,537.41,539.912,543.413,545.663" svgx:width="0.28,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.78,0.44,0.33,0.5,0.5,0.39,0.25,0.33,0.44,0.78,0.28,0.33,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ized by numerous ramified processes, and putative myelin balls, </text>
   <text y="318.915" x="310.016,316.514,321.014,325.01,328.007,332.003,335.999,339.5,341.642,348.14,353.144,358.643,361.64,366.644,372.647,378.65,383.15,385.292,391.79,395.786,399.287,401.429,403.931,408.431,412.427,415.262,418.259,422.255,426.251,428.753,431.255,435.755,439.751,442.001,443.981,449.48,453.98,457.976,460.118,464.618,467.615,472.115,474.617,477.119,480.116,484.112,487.109,491.105,493.607,496.109,500.609,505.109,507.251,511.751,514.748,516.89,523.388,528.554,530.696,535.196,538.193,542.693" svgx:width="0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.72,0.56,0.61,0.33,0.56,0.67,0.67,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.61,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">whereas NFL-SCR2 was ineffective. The proliferation of OL pro-</text>
   <text y="329.913" x="310.016,314.516,318.512,323.012,325.514,328.016,332.516,335.513,339.014,341.66,348.158,352.154,355.655,358.301,362.801,367.301,369.803,372.449,376.445,379.28,382.277,386.273,390.269,392.771,396.767,401.267,403.517,406.163,410.663,415.163,418.16,420.806,427.304,431.3,434.801,436.952,443.45,448.454,451.1,455.6,458.597,463.097,465.599,468.101,471.098,475.094,478.091,482.087,484.589,487.091,491.591,496.091,498.737,502.733,507.233,511.733,514.379,518.879,521.381,524.216,527.213,531.209,534.206,538.202,542.702" svgx:width="0.5,0.44,0.5,0.28,0.28,0.5,0.33,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.25,0.5,0.5,0.33,0.25,0.72,0.44,0.39,0.25,0.72,0.56,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">genitors was not affected, nor was AS proliferation and differen-</text>
   <text y="340.911" x="310.016,312.518,315.02,319.016,321.518,324.02,328.52,333.02,335.27,338.051,343.055,347.555,351.056,355.556,360.056,364.556,369.056,372.557,377.057,381.557,385.553,388.055,390.557,395.057,399.557,402.059,404.84,408.836,413.336,417.836,420.338,422.84,427.34,431.336,434.117,437.114,442.613,447.617,453.62,455.87,458.651,463.151,465.401,468.182,472.682" svgx:width="0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.39,0.5,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.33,0.61,0.56,0.67,0.25,0.25,0.5,0.25,0.25,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tiation. Lysophosphatidyl choline (LPC, 2. 10</text>
   <text y="338.439" x="477.2,479.148" svgx:width="0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">-5</text>
   <text y="340.959" x="482.073,484.854,492.855,495.105,497.886,502.386,506.886,511.386,514.383,517.164,519.666,524.166,528.666,533.166,537.162,541.158,545.658" svgx:width="0.25,0.89,0.25,0.25,0.5,0.5,0.5,0.33,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> M, 24h) induced </text>
   <text y="351.957" x="310.02,316.518,321.684,324.051,328.551,332.547,336.543,339.045,343.545,345.912,348.909,352.905,355.902,360.402,364.902,369.402,373.902,376.269,380.769,385.269,392.766,395.763,398.013,400.38,406.878,411.378,415.374,418.371,422.367,426.363,429.864,432.231,434.733,439.233,441.6,445.596,450.096,452.598,455.1,459.6,462.597,466.593,470.094,472.461,476.457,480.957,483.954,486.456,489.453,493.449,497.445,499.947,503.943,508.443,510.81,517.308,519.81,522.312,526.812,529.179,534.678,539.682,545.685" svgx:width="0.72,0.61,0.25,0.5,0.44,0.44,0.28,0.5,0.25,0.33,0.44,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.5,0.83,0.33,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.39,0.25,0.44,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.61,0.56,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">OL death (around 50%), whereas in cultures co-treated with LPC </text>
   <text y="362.955" x="310.02,314.016,318.516,323.016,325.419,331.917,336.921,342.42,345.417,350.916,356.919,361.923,364.173,368.673,373.173,376.17,380.67,385.17,387.573,394.071,399.237,401.64,405.141,409.641,412.638,417.138,419.64,424.14,428.136,430.638,432.888,435.291,439.791,442.293,445.128,448.125,452.121,455.118,459.114,463.614,466.116,468.618,472.614,475.116,477.618,482.118,486.618,488.868,491.271,495.267,499.767,504.267,506.67,513.672,517.668,520.17,524.67,527.667,531.663,534.165,536.667,541.167,545.667" svgx:width="0.44,0.5,0.5,0.25,0.72,0.56,0.61,0.33,0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.72,0.61,0.25,0.39,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.25,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and NFL-TBS.40-63 OL survival, differentiation, and maturation </text>
   <text y="373.953" x="310.02,316.518,320.514,323.511,327.507,329.757,331.431,334.932,337.434,341.934,346.434,348.936,351.933,354.435,358.431,362.427,366.927,369.429,371.931,376.431,378.681,380.355,383.352,387.348,390.849,394.845,399.345,403.341,407.841,410.091,412.341,413.853,419.352,423.852,427.848,430.098,431.772,438.27,443.436,445.686,447.36,451.356,455.856,458.358,462.858,466.359,470.859,474.855,477.357,481.353,483.855,488.355,492.855,495.105,496.779,501.279,505.275,507.777,514.275,518.775,521.772,526.272,528.522,530.196,534.192,538.692,542.688" svgx:width="0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.44,0.5,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.72,0.61,0.25,0.55,0.44,0.5,0.28,0.5,0.39,0.5,0.44,0.28,0.44,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were significantly rescued. The OL cytoskeleton network ana-</text>
   <text y="384.951" x="310.02,312.522,317.022,321.018,325.014,329.514,331.692,336.192,340.692,342.87,345.372,352.374,359.376,363.876,368.376,372.876,376.872,381.372,383.874,388.374,392.37,396.87,400.866,407.868,410.37,413.871,416.373,419.37,423.87,426.048,432.546,435.048,437.55,442.05,444.228,446.73,451.23,455.73,460.23,462.732,465.234,469.734,473.73,475.98,478.158,480.66,484.656,489.156,491.334,495.33,499.83,504.33,506.508,514.509,521.007,526.011,529.512,531.69,538.188,542.184,545.685" svgx:width="0.28,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.39,0.28,0.33,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.25,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.89,0.72,0.56,0.39,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lyzed by immunocytochemistry with tubuline, tau and MAPs was </text>
   <text y="395.949" x="310.02,314.52,319.02,321.522,323.772,324.537,328.533,331.035,333.537,337.533,340.53,344.526,349.026,351.276,352.041,356.541,361.041,363.291,364.056,366.558,371.058,375.054,377.304,378.069,382.569,386.565,391.065,393.567,396.069,400.569,404.565,406.815,407.58,410.082,413.079,417.075,421.071,423.573,430.575,434.571,439.071,441.573,443.823,446.676,452.175,456.675,460.671,462.921,463.686,466.188,470.688,473.19,476.187,480.183,484.179,488.175,490.677,493.179,497.679,500.181,504.177,507.174,509.424,510.189,513.69,516.193,520.693,525.193,529.188,531.69,534.193,536.695,541.195,545.695" svgx:width="0.5,0.5,0.28,0.25,0.55,0.44,0.28,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.28,0.5,0.28,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">not altered by the peptide treatment. The intracellular signalling </text>
   <text y="406.947" x="310.02,314.52,318.516,321.018,325.518,332.016,336.012,340.512,343.194,345.696,350.196,354.696,359.196,361.698,366.198,370.194,374.694,377.376,381.876,385.872,389.373,392.055,396.555,401.055,403.557,406.239,410.739,414.735,418.731,423.231,425.913,428.415,432.915,436.911,441.411,443.913,446.415,449.412,451.914,455.91,460.41,463.092,467.592,471.588,474.09,476.34,479.022,483.522,487.518,492.018,496.014,499.011,501.513,506.013,510.009,512.511,516.507,520.008,523.509,526.191,530.691,533.193,537.693,540.195,542.697" svgx:width="0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.25,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.28,0.44,0.39,0.39,0.25,0.5,0.28,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pathway involved has not been identified yet, nevertheless bioti-</text>
   <text y="417.945" x="310.02,314.52,319.02,321.522,325.518,328.02,332.016,336.516,338.766,339.594,344.094,348.09,352.59,355.092,357.594,362.094,366.09,369.591,371.841,372.669,379.167,383.163,386.16,390.156,392.406,393.234,395.736,400.236,404.232,408.228,410.73,413.232,417.228,421.224,425.724,427.974,428.802,431.304,435.804,438.306,442.806,445.056,445.884,448.386,452.886,456.882,459.132,459.96,466.962,470.958,473.46,477.96,480.21,481.038,485.538,488.535,493.035,497.031,501.027,504.528,508.029,512.025,515.526,517.776,518.604,522.6,527.1,531.6,533.85,534.678,537.18,541.68,545.676" svgx:width="0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nylated peptides were localized into the main processes and the </text>
   <text y="428.943" x="310.02,314.52,318.516,321.513,324.015,328.515,333.015,337.011,339.513,343.509,347.505,350.502,352.662,356.658,361.158,363.66,368.16,372.66,375.162,379.158,382.659,389.661,391.821,396.321,399.318,401.478,407.481,413.979,418.983,424.059,426.219,432.717,437.883,440.043,444.543,449.043,451.203,455.199,459.699,464.199,467.196,471.696,475.692,479.688,482.19,484.35,491.352,493.854,497.85,500.847,505.347,508.848,512.844,517.344,521.844,525.759,528.009,530.169,533.67,538.17,542.67" svgx:width="0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.44,0.39,0.78,0.25,0.5,0.33,0.25,0.67,0.72,0.56,0.56,0.25,0.72,0.61,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.28,0.25,0.78,0.28,0.44,0.33,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">perinuclear cytoplasm of CNP+ OL by confocal microscopy, sug-</text>
   <text y="439.941" x="310.02,314.52,318.516,322.017,324.519,327.021,331.521,336.021,338.271,342.267,346.767,351.267,355.767,359.763,364.263,366.765,371.265,374.766,377.268,380.769" svgx:width="0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.5,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gesting endocytosis.</text>
   <text y="450.939" x="310.02,316.518,321.018,326.022,330.018,332.52,337.524,341.025,343.527,348.027,353.031,356.532,359.529" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="450.939" x="364.551,370.05,374.55,379.05,382.551,384.801,387.573,390.075,393.072,395.322,398.094,400.596,405.096,409.092,411.342,414.114,417.111,421.107,423.609,427.605,431.601,435.102,439.098,441.348,444.12,448.62,451.617,453.867,456.639,461.139,465.135,469.635,472.137,474.639,479.139,483.135,486.636,488.886,491.658,495.159,499.659,503.655,508.155,510.405,513.177,517.173,520.674,522.924,525.696,532.194,537.198,542.697" svgx:width="0.61,0.5,0.5,0.39,0.25,0.55,0.28,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.39,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.72,0.56,0.61,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Thus if the release of peptides such as NFL-</text>
   <text y="461.937" x="310.02,315.519,321.522,326.526,328.776,333.276,337.776,340.773,345.273,349.773,352.023,354.165,358.665,362.661,366.657,371.157,374.154,377.655,379.905,382.047,384.549,389.049,391.299,393.441,397.941,400.443,404.943,409.443,411.693,413.835,416.832,421.332,423.834,426.336,430.836,437.334,439.836,444.336,448.836,451.086,453.228,457.224,461.724,466.224,470.724,474.72,477.222,479.472,481.614,486.114,490.11,497.112,501.108,505.608,509.604,511.854,514.104,516.246,518.748,521.25,523.5,525.642,529.638,534.138,538.638,541.14,545.64" svgx:width="0.61,0.67,0.56,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.25,0.55,0.28,0.28,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TBS.40-63 occurs in vivo following axonal damage, it could </text>
   <text y="472.935" x="310.02,312.522,319.524,324.024,327.021,331.521,336.021,340.017,342.222,345.219,349.215,353.715,357.711,360.213,363.21,365.415,367.917,372.417,375.414,379.914,384.414,388.914,393.414,395.619,398.121,402.621,406.617,409.614,413.61,417.606,421.107,425.103,429.603,431.808,438.306,443.472,445.677,450.177,452.679,455.514,458.511,462.507,465.504,469.5,474.0,476.502,479.004,483.0,485.502,488.004,492.504,497.004,499.209,503.205,507.705,512.205,514.41,517.911,522.411,525.408,529.908,532.41,536.91,540.906,543.408,545.658" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.33,0.44,0.5,0.44,0.28,0.33,0.25,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.72,0.61,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improve repair through increased OL differentiation and survival, </text>
   <text y="483.933" x="310.02,316.518,321.018,323.52,327.516,332.016,334.716,337.218,340.719,343.419,347.415,350.115,354.615,357.612,361.608,364.605,368.601,373.101,377.601,380.103,383.604,386.106,388.608,392.604,395.304,398.301,402.801,405.798,408.498,411.495,415.491,422.493,426.993,430.989,433.491,435.993,440.493,444.489,446.991,449.493,453.993,458.493,460.743,463.281,468.78,473.28,477.276,479.976,482.478,486.978,490.974,493.971,497.967,502.467,506.463,510.963,513.465,515.967,519.963,522.663,527.163,531.663,534.165,538.161,542.661" svgx:width="0.72,0.5,0.28,0.44,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.33,0.44,0.33,0.44,0.5,0.5,0.28,0.39,0.28,0.28,0.44,0.25,0.33,0.5,0.33,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.44,0.25,0.5,0.5,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">which is a prerequisite for remyelination. The therapeutic poten-</text>
   <text y="494.931" x="310.02,312.522,315.024,319.02,321.522,323.538,328.038,331.035,333.051,335.553,340.053,344.049,346.065,350.565,354.561,359.061,361.563,364.065,368.565,372.561,374.577,377.574,384.072,388.572,391.074,395.07,399.57,401.586,405.582,410.082,414.582,418.578,422.574,425.571,429.072,431.088,435.588,440.088,444.588,446.604,449.106,453.606,458.106,460.608,464.604,467.601,469.617,476.115,478.617,481.119,483.621,485.637,490.137,494.133,496.149,500.649,504.645,507.147,511.143,514.14,521.142,523.644,528.144,532.14,536.64,538.656,541.158,545.658" svgx:width="0.28,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.28,0.28,0.5,0.44,0.25,0.33,0.72,0.5,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.5,0.5,0.25,0.28,0.5,0.5,0.28,0.44,0.33,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tial of the peptide (which appears non toxic) will be determined in </text>
   <text y="505.929" x="310.02,314.52,317.022,321.522,326.022,328.272,332.772,337.272,339.522,344.022,348.018,352.014,356.514,358.764,361.266,365.766,368.268,371.265,375.261,379.761,383.757,390.759,393.261,396.762,401.262,405.762,409.758,412.755,415.257,419.253,421.503,428.505,431.007,435.003,438.0,442.5,445.002,449.502,452.004,456.0,459.996,462.498,465.0,469.5,474.0" svgx:width="0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.28,0.33,0.44,0.5,0.44,0.78,0.28,0.39,0.5,0.5,0.44,0.33,0.28,0.44,0.25,0.78,0.28,0.44,0.33,0.5,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vivo by deep intrahemispheric microinjection.</text>
   <text y="532.929" x="310.02,315.519,320.019,324.519" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P623</text>
   <text y="543.927" x="310.02,316.518,319.02,322.017,325.014,329.01,333.006,337.002,342.006,345.003,347.505,352.005,354.507,356.757,361.257,363.759,368.259,372.255,376.755,380.256,384.756,387.258,391.758,394.755,397.257,401.757,406.761,409.011,413.511,416.508,418.758,425.76,429.261,435.759,440.259,442.509,447.009,449.259,451.761,456.765,459.015,463.515,466.017,468.519,473.019,475.269,479.265,483.261,485.763,488.265,491.766,494.016,498.516,501.513,504.51,508.506,512.502,515.499,519.0" svgx:width="0.72,0.28,0.33,0.33,0.44,0.44,0.44,0.56,0.33,0.28,0.5,0.28,0.25,0.5,0.28,0.5,0.44,0.5,0.39,0.5,0.28,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.78,0.39,0.72,0.5,0.25,0.5,0.25,0.28,0.56,0.25,0.5,0.28,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.33,0.33,0.44,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Differential glycosylation of KIR4.1 in glia cells affects </text>
   <text y="554.925" x="310.02,315.024,317.526,322.53,327.534,330.036,335.04,339.54,341.79,346.29,349.287,351.537,356.037,361.041,364.038,368.538,373.038,378.042,381.039,383.541,388.545,393.045,398.049,400.551,404.547,408.048,410.298,412.8,417.804,420.054,427.551,432.555,435.057,438.054,440.556,445.56,448.062,452.058,454.308,457.809,461.805,464.307,468.303,472.299,476.799,480.3,482.802" svgx:width="0.56,0.28,0.56,0.56,0.28,0.56,0.5,0.25,0.5,0.33,0.25,0.5,0.56,0.33,0.5,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.28,0.44,0.39,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">binding of autoantibodies in multiple sclerosis</text>
   <text y="565.923" x="310.02,316.023,318.273,323.277,326.274,328.776,333.276,337.272,340.773,343.275,347.271,351.771" svgx:width="0.67,0.25,0.56,0.33,0.28,0.5,0.44,0.39,0.28,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">R Srivastava</text>
   <text y="563.439" x="355.762" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="565.959" x="358.687,360.937,363.187,368.191,374.194,376.444,382.942,386.938,389.44,391.942,396.442,399.439" svgx:width="0.25,0.25,0.56,0.67,0.25,0.72,0.44,0.28,0.28,0.5,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, SR Kalluri</text>
   <text y="563.439" x="401.941" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="565.959" x="404.866,407.116,409.366,415.864,418.114,423.118,427.114,431.614,435.61,438.607,442.603" svgx:width="0.25,0.25,0.72,0.25,0.56,0.44,0.5,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, Y SchÃ¤fer</text>
   <text y="563.439" x="445.599" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="565.959" x="448.524,450.774,453.024,459.522,461.772,468.27,471.267,475.767,482.769,489.771,493.767" svgx:width="0.25,0.25,0.72,0.25,0.72,0.33,0.5,0.78,0.78,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Grummel</text>
   <text y="563.439" x="496.269" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="565.959" x="499.194,501.444,503.694,509.193" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E </text>
   <text y="576.957" x="310.014,316.512,319.509,323.505,330.507,337.509,341.505" svgx:width="0.72,0.33,0.44,0.78,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Kremmer</text>
   <text y="574.439" x="344.503" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="576.959" x="347.428,349.678,351.928,358.426,360.676,366.679,371.179,375.175" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Buck</text>
   <text y="574.439" x="379.675" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="576.959" x="382.6,384.85,387.1,392.599,394.849,399.853,403.849,408.349,410.851,413.848,420.85,424.846" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.5,0.28,0.33,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Schirmer</text>
   <text y="574.439" x="427.842" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="576.959" x="430.767,433.017,435.267,441.27,443.52,450.018,454.014,461.016,468.018,472.014" svgx:width="0.25,0.25,0.67,0.25,0.72,0.44,0.78,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Hemmer</text>
   <text y="574.439" x="475.011" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="585.437" x="310.018" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="587.959" x="312.941,317.945,321.941,325.937,330.437,334.937,337.439,340.94,344.936,349.436,353.432,355.682,362.18,366.68,369.182,373.178,377.174,380.675,384.176,386.678,389.18,393.68,396.182,398.432,400.682,408.179,412.679,417.179,419.681,423.677,428.177,430.427,432.677,439.175,443.171,446.672,453.17,457.67,462.17,466.166,468.416" svgx:width="0.56,0.44,0.44,0.5,0.5,0.28,0.39,0.44,0.5,0.44,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.28,0.25,0.25,0.83,0.5,0.5,0.28,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Technische UniversitÃ¤t, Munich, Germany, </text>
   <text y="585.439" x="470.664" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="587.959" x="473.589,480.087,484.083,486.585,493.083,497.583,502.083,504.585,507.087,510.588,512.838,517.842,521.838,526.338,528.84,532.341,536.841,543.339" svgx:width="0.72,0.44,0.28,0.72,0.5,0.5,0.28,0.28,0.39,0.25,0.56,0.44,0.5,0.28,0.39,0.5,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Helmholtz Zentrum </text>
   <text y="598.957" x="310.014,317.511,322.011,326.511,330.507,335.007,339.003,343.503,345.753,348.003,354.006,358.506,362.007,366.003,368.253,373.752,378.252,382.248,384.75,387.252,389.754,392.256,396.252,398.502,405.999,410.499,414.999,419.499,423.495,425.997,430.497,434.997,439.497,441.999,444.249,449.748,454.248,456.75,459.252,463.752,468.252,472.752,475.254,479.25,482.751,485.001,487.251,494.748,499.248,503.748,506.25,510.246,514.746,516.996" svgx:width="0.83,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.67,0.5,0.39,0.44,0.25,0.61,0.5,0.44,0.28,0.28,0.28,0.28,0.44,0.25,0.83,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.5,0.28,0.25,0.61,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.83,0.5,0.5,0.28,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">MÃ¼nchen, Core Facility Monoclonal Antibodies, Munich, </text>
   <text y="609.955" x="310.014,316.512,320.508,324.009,330.507,335.007,339.507" svgx:width="0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Germany</text>
   <text y="636.955" x="310.014,316.017,320.517,324.513,329.517,334.017,337.851,342.351,347.355,352.359,357.363,360.36" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="636.955" x="363.087,366.084,370.584,377.082,381.078,384.075,388.575,391.302,394.299,398.295,402.291,404.793,407.295,410.292,414.792,417.294,421.794,426.294,429.021,433.521,438.021,440.523,444.519,448.02,451.521,454.023,458.523,465.525,468.252,472.248,476.748,480.744,485.244,489.744,493.74,496.242,498.969,503.469,505.719,510.219,512.946,515.943,522.441,525.438,531.441,535.941,538.191,542.691,545.688" svgx:width="0.33,0.5,0.72,0.44,0.33,0.5,0.25,0.33,0.44,0.44,0.28,0.28,0.33,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.28,0.44,0.39,0.39,0.28,0.5,0.78,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.28,0.25,0.5,0.25,0.5,0.25,0.33,0.72,0.33,0.67,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Inward rectifying potassium channel 4.1 (KIR4.1) </text>
   <text y="647.953" x="310.014,313.515,318.015,322.011,326.007,328.509,331.506,334.008,338.004,340.254,341.595,345.096,349.092,352.089,356.589,363.591,365.841,367.182,371.178,375.678,378.18,380.682,385.182,389.682,394.182,396.684,400.68,404.181,406.431,407.772,414.27,418.266,421.263,425.259,427.509,428.85,431.847,435.843,440.343,444.843,447.84,450.342,454.338,458.838,461.088,462.429,464.931,469.431,471.681,473.022,477.018,479.268,480.609,484.11,488.61,493.11,496.107,500.607,505.107,509.607,514.107,516.609,520.605,523.107,525.609,530.109,534.609,536.859,538.2,542.7,545.697" svgx:width="0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">specific serum antibodies were reported in a sub-population of </text>
   <text y="658.951" x="310.014,317.016,321.516,324.018,326.52,329.022,333.522,336.024,340.02,341.919,345.42,349.416,351.918,355.914,358.911,363.411,366.912,369.414,372.915,374.814,377.811,385.812,390.816,393.813,395.712,400.212,404.208,406.71,409.212,413.208,417.708,420.21,423.711,425.961,427.86,434.358,437.355,443.358,447.858,450.108,454.608,456.507,459.009,462.51,464.409,468.405,470.304,474.804,477.306,481.806,485.802,490.302,493.803,498.303,500.805,504.801,507.303,511.299,515.799,517.698,521.694,526.194,530.19,534.69,539.19,543.186,545.688" svgx:width="0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.72,0.33,0.67,0.5,0.25,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.28,0.5,0.44,0.5,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multiple sclerosis (MS) patients. KIR4.1 is a glycosylated channel </text>
   <text y="669.949" x="310.014,314.514,317.511,322.011,324.513,328.509,331.011,335.511,337.761,341.757,346.257,350.757,353.754,357.75,361.251,364.752,368.748,373.248,375.498,378.0,382.5,384.75,389.25,391.752,394.254,398.754,403.254,407.754,411.75,416.25,420.75,423.747,428.247,432.243,436.743,439.245,443.241,446.742,448.992,452.988,457.488,461.988,464.238,468.234,470.484,473.985,478.485,482.985,486.486,490.482,492.984,495.234,499.734,502.731,504.981,508.977,512.478,514.98,517.977,522.477,526.473,530.973,533.475,537.471,540.972" svgx:width="0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.25,0.5,0.33,0.25,0.44,0.39,0.28,0.33,0.5,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">protein expressed in oligodendrocytes and a subset of astrocytes.</text>
   <text y="680.947" x="310.014,317.016,322.02,325.017,329.013,333.009,336.006,338.508,343.008,347.004,350.505,353.502" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="680.947" x="356.724,361.593,366.093,368.343,369.315,373.815,377.811,380.313,384.309,387.306,394.308,396.81,401.31,405.306,407.556,408.528,411.03,415.53,419.526,421.776,422.748,427.248,431.748,435.249,437.751,440.253,443.25,447.246,451.746,455.247,457.749,461.745,464.247,466.749,471.249,475.749,479.745,482.247,484.497,485.469,492.471,496.971,501.471,503.973,506.97,509.472,513.468,517.464,519.966,522.468,526.968,531.468,534.969,537.219,538.191,542.691,545.688" svgx:width="0.61,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.28,0.28,0.33,0.44,0.5,0.39,0.28,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To determine the posttranslational modifications of </text>
   <text y="691.945" x="310.014,316.512,319.509,325.512,330.012,332.262,336.762,339.012,340.029,344.529,348.525,352.521,357.021,360.018,363.015,365.517,370.017,374.517,376.767,377.784,380.286,384.786,387.036,388.053,392.553,397.053,404.055,408.051,412.551,414.801,415.818,420.318,423.315,427.311,429.813,434.313,436.563,437.58,441.576,446.076,450.576,452.826,453.843,456.345,460.845,464.841,467.343,470.34,472.59,473.607,476.109,483.111,487.611,491.607,495.603,498.105,500.355,501.372,505.872,510.372,512.6220000000001,513.639,517.635,522.135,524.637,529.137,533.133,537.633,540.135,542.637" svgx:width="0.72,0.33,0.67,0.5,0.25,0.5,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">KIR4.1 occurring in human brain and their impact on autoanti-</text>
   <text y="702.943" x="310.014,314.514,319.014,323.514,328.014,330.264,334.764,337.266,341.766,346.266,348.768,353.268,357.768" svgx:width="0.5,0.5,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">body binding.</text>
   <text y="713.941" x="310.014,318.375,322.236,325.098,329.967,334.332,339.201,342.567,345.429" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="713.941" x="349.758,356.121,358.983,364.851,369.216,371.331,375.696,377.946,380.025,384.39,387.252,391.617,393.984,397.845,400.212,404.577,406.827,408.906,415.269,419.13,422.496,424.746,426.825,429.192,432.558,436.923,439.29,443.151,445.518,449.379,453.744,455.994,458.073,460.935,463.797,468.162,475.029,477.279,479.358,483.723,488.088,494.955,498.816,503.181,505.431,507.51,510.876,515.241,519.606,523.467,527.832,530.694,533.061,535.428,539.289,543.15,545.652" svgx:width="0.72,0.33,0.67,0.5,0.25,0.5,0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.44,0.5,0.33,0.28,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">KIR4.1 protein was isolated from human subcortical </text>
   <text y="724.939" x="310.014,316.377,320.742,323.109,325.476,329.337,331.587,332.559,336.42,340.785,345.15,347.4,348.372,352.233,356.598,359.46,361.827,364.194,368.055,371.916,374.283,376.533,377.505,381.87,384.732,388.593,392.958,395.208,396.18,403.047,406.908,409.275,411.642,415.503,418.365,420.615,421.587,425.448,429.813,434.178,436.428,437.4,439.767,442.629,446.49,450.855,454.221,457.083,460.944,464.805,467.172,471.033,475.398,477.648,478.62,484.983,490.347,496.71,501.075,505.44,509.805,512.0550000000001,513.027,516.888,520.749,523.116,525.483,528.849,530.964,533.214,534.024,541.665,545.661" svgx:width="0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.28,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.44,0.5,0.25,0.55,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.61,0.72,0.5,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.94,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">white and cortical gray matter and transfected HEK293 cells. We </text>
  </g>
 </g>
</svg>
